Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M7CB
|
||||
Former ID |
DIB014984
|
||||
Drug Name |
MK-0873
|
||||
Synonyms |
MK-0873 (dermatological, psoriasis); MK-0873 (dermatological, psoriasis), Merck & Co
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psoriasis [ICD9: 696; ICD10:L40] | Phase 2 | [521664] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H18N4O3
|
||||
Canonical SMILES |
c1cc2c(n(cc(c2=O)C(=O)NC2CC2)c2cccc(c2)C#Cc2c[n+](ccc2)<br />[O-])nc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [529356] | |
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [529356] | ||
Type IV phosphodiesterase | Target Info | Inhibitor | [529356] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.